Betty Yang is a partner in the Dallas office of Gibson, Dunn & Crutcher.  Ms. Yang focuses her practice on complex civil litigation, helping clients to navigate disputes in a variety of contexts, including antitrust, intellectual property, life sciences, and oil & gas.

Ms. Yang’s extensive experience as a trial lawyer includes some of the most significant trials of the last 20 years.  In a case described in the press as “the Super Bowl of Antitrust,” Ms. Yang represented a leading technology firm in defending unprecedented antitrust claims, deposing key witnesses, arguing evidentiary motions at trial, and developing the examinations of both companies’ CEOs.  In another representative matter, Ms. Yang performed direct and cross examinations of several key fact and expert witnesses in a $10 billion arbitration regarding the construction of an oil refinery, obtaining a unanimous take-nothing judgment for her clients.  Earlier in her career, Ms. Yang represented BP America Production Co. in the multidistrict litigation relating to the sinking of the Deepwater Horizon and was the youngest attorney to take depositions, including one notable deposition that received national press coverage and led to the imposition of sanctions against Halliburton.

For these and other trial achievements, Ms. Yang was recognized as one of Business Insider’s 2022 “Rising Stars of the Courtroom” and one of Texas Lawyer’s 2022 attorneys “On the Rise.”

Other Representative Matters*

• Co-lead trial counsel for Fortune 100 company in case alleging patent infringement, fraud, and breach of contract in connection with a medical device. Case reached favorable settlement soon after trial began.
• Trial counsel for national insurance company in highly publicized month-long trial relating to confirmation of bankruptcy plan filed by insured, a national nonprofit with over a million members.
• Trial counsel for pharmaceutical company client in False Claims Act qui tam suit brought by a generic competitor. Obtained full dismissal and award of costs and attorneys’ fees for client.
• Represented global pharmaceutical company in antitrust action asserting novel “product switching” or “product hopping” theory brought by generic pharmaceutical manufacturer.
• Represented leading fintech company in litigation brought by Federal Trade Commission alleging violations of Section 5 of the FTC Act and Gramm-Leach-Bliley Act in company’s personal and auto loan businesses.
• Represented major oil and gas company in litigation relating $500 million acquisition of midstream assets.
• Advised major midstream company regarding litigation risk associated with potential $500 million acquisition.
• Advised national life insurance and financial services company on updates and modifications to marketing practices to mitigate risk of enforcement action by Federal Trade Commission.

*Includes matters handled prior to joining Gibson, Dunn & Crutcher LLP.

Outside of the courtroom, Ms. Yang is committed to advancement of the legal profession on issues of equality and justice.  Ms. Yang maintains an active pro bono practice and serves on the board of directors for the Human Rights Initiative of North Texas.  Ms. Yang also serves as the co-chair of the Texas chapter of the ChIPs Network, an organization that advances and connects women in technology, law, and policy.

Ms. Yang received her Juris Doctor from Duke University School of Law.  Ms. Yang received her Bachelor of Arts degree in Chemistry from Emory University.  During college, Ms. Yang worked in the physiology department of Emory University School of Medicine, where she studied the myosin heavy chain composition of the styloglossus muscle in rhesus macaque monkeys.

Ms. Yang is a member of the Texas Bar.  She is proficient in Mandarin Chinese.